Aug 19, 2024, 10:56
Katie Coleman: Excited to hear about OncoPrimary as an emerging field
Katie Coleman shared a post on X:
“One of the single most difficult corners of my care pre-diagnosis, through active treatment and into post-treatment/surveillance. Excited to hear about OncoPrimary as an emerging field. Excellent session and such an unmet need for so many.”
Source: Katie Coleman/X
Katie Coleman, Product and Engineering Lead at the Rare Cancer Research Foundation and President of the Chromophobe and Oncocytic Tumor Alliance (COA), is a dedicated software engineer with a mission for creating intuitive, user-friendly products.
As a rare kidney cancer survivor, she is deeply committed to medical research and advocacy. Her personal experience helps her to promote collaborations that advance rare cancer research.